News
📈 Stocks
Telix Pharmaceuticals Shares Slide Following $2.35 Billion ITM Merger Deal
(50 days ago)
Telix Pharmaceuticals stock drops as markets digest a $2.35 billion merger with Isotope Technologies Munich, overshadowing analyst optimism for the radiopharmaceutical firm.